UBS Group AG - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 33 filers reported holding CANCER GENETICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2019$13,000
-7.1%
121,511
+43.9%
0.00%
Q2 2019$14,00084,463
+28054.3%
0.00%
Q1 2019$0
-100.0%
300
-98.4%
0.00%
Q4 2018$5,000
+25.0%
19,242
+395.4%
0.00%
Q3 2018$4,000
-42.9%
3,884
-54.2%
0.00%
Q2 2018$7,000
-93.0%
8,476
-86.1%
0.00%
Q1 2018$100,000
-64.9%
60,854
-60.6%
0.00%
Q4 2017$285,000
-62.2%
154,460
-44.6%
0.00%
Q3 2017$753,000
-7.2%
279,036
+35.9%
0.00%
Q2 2017$811,000
+81000.0%
205,358
+68352.7%
0.00%
Q1 2017$1,0000.0%300
-55.8%
0.00%
Q4 2016$1,000
-66.7%
678
-60.1%
0.00%
Q3 2016$3,0000.0%1,7000.0%0.00%
Q2 2016$3,000
-91.7%
1,700
-86.4%
0.00%
Q1 2016$36,000
-7.7%
12,477
+4.7%
0.00%
Q4 2015$39,000
-49.4%
11,915
+21.6%
0.00%
Q3 2015$77,000
+196.2%
9,800
+336.5%
0.00%
Q2 2015$26,000
+136.4%
2,245
+60.4%
0.00%
Q1 2015$11,000
-73.2%
1,400
-77.3%
0.00%
Q4 2014$41,0006,1760.00%
Other shareholders
CANCER GENETICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 836,908$3,431,0003.54%
Fairbanks Capital Management, Inc. 233,170$956,0000.94%
DIKER MANAGEMENT LLC 63,315$260,0000.12%
EAM Investors, LLC 117,878$483,0000.08%
WEDBUSH SECURITIES INC 87,000$357,0000.05%
Acrospire Investment Management LLC 11,090$45,0000.04%
TWO SIGMA SECURITIES, LLC 16,053$66,0000.01%
THOMPSON DAVIS & CO., INC. 2,000$8,0000.01%
Manchester Capital Management LLC 9,000$37,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 40,158$165,0000.00%
View complete list of CANCER GENETICS INC shareholders